Page last updated: 2024-11-06

thiolactic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

thiolactic acid: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID62326
CHEMBL ID2158192
CHEBI ID47872
SCHEMBL ID15864
MeSH IDM0081626

Synonyms (57)

Synonym
2-mercaptopropanoic acid
thiolactic acid
einecs 201-206-5
thiolactic acid [un2936] [poison]
brn 0506218
un2936
fema no. 3180
propionic acid, 2-mercapto-
propanoic acid, 2-mercapto-
thiolactic acid, 95%
2-mercaptopropionic acid, >=95%, fg
2-sulfanylpropanoic acid
2-thiolactic acid
2-mercaptopropionic acid
alpha-mercaptopropanoic acid
alpha-mercaptopropionic acid
CHEBI:47872 ,
2-thiolpropionic acid
79-42-5
M0060
AKOS000120478
rac-thiolactic acid
CHEMBL2158192
BBL011561
4-03-00-00682 (beilstein handbook reference)
thiolactic acid [un2936] [poison]
o5u6967kgf ,
unii-o5u6967kgf
STL146731
(+/-)-2-mercaptopropionic acid
thiolactic acid [fhfi]
thiolactic acid [mi]
thiolactic acid [inci]
AKOS017278454
SCHEMBL15864
un 2936
.alpha.-mercaptopropionic acid
.alpha.-mercaptopropanoic acid
mercapto-propionic acid
2-mercapto propionic acid
2-mercapto-propionic acid
Q-200297
mfcd00004862
F2191-0225
2-mercaptopropionic acid, analytical standard
2-mercapto-propanoic acid
fema 3180
alpha -mercaptopropionic acid
alpha -mercaptopropanoic acid
DTXSID80861636
Q27120833
STR01228
E78835
FT-0778104
EN300-20156
Z104477082
PD123987

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Our results suggest that thiol-induced oxidation of Hg(0)aq is important under anoxic conditions and can affect Hg redox transformation and bioavailability for microbial methylation."( Oxidation of dissolved elemental mercury by thiol compounds under anoxic conditions.
Gu, B; Liang, L; Lin, H; Mann, BF; Zheng, W, 2013
)
0.39

Dosage Studied

ExcerptRelevanceReference
"A simple and fast high-performance liquid chromatographic method was developed for the simultaneous measurement of 2-mercaptopropionylglycine (Tiopronine) and its metabolite (2-mercaptopropionic acid) in human plasma after the administration of a pharmaceutical dosage form (Acadione)."( Determination of 2-mercaptopropionylglycine and its metabolite, 2-mercaptopropionic acid, in plasma by ion-pair reversed-phase high-performance liquid chromatography with post-column derivatization.
Bannwarth, B; Gavriloff, C; Hercelin, B; Leroy, P; Matt, M; Mazza, M; Netter, P; Nicolas, A, 1991
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
mercaptopropanoic acid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID695877Cytotoxicity against human KB-3-1 cells incubated for 72 hrs by MTT assay2011Journal of medicinal chemistry, Jul-28, Volume: 54, Issue:14
Collateral sensitivity of multidrug-resistant cells to the orphan drug tiopronin.
AID695851Resistance index, ratio of IC50 for human KB-3-1 cells to IC50 for drug-resistant human KBV1 cells expressing P-gp2011Journal of medicinal chemistry, Jul-28, Volume: 54, Issue:14
Collateral sensitivity of multidrug-resistant cells to the orphan drug tiopronin.
AID695876Cytotoxicity against drug-resistant human KBV1 cells expressing P-gp incubated for 72 hrs by MTT assay2011Journal of medicinal chemistry, Jul-28, Volume: 54, Issue:14
Collateral sensitivity of multidrug-resistant cells to the orphan drug tiopronin.
AID1128913Inhibition of metallo-beta-lactamase IMP-1 (unknown origin)2014European journal of medicinal chemistry, Apr-09, Volume: 76The applications of binuclear metallohydrolases in medicine: recent advances in the design and development of novel drug leads for purple acid phosphatases, metallo-β-lactamases and arginases.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (46)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (21.74)18.7374
1990's10 (21.74)18.2507
2000's9 (19.57)29.6817
2010's15 (32.61)24.3611
2020's2 (4.35)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.52 (24.57)
Research Supply Index3.87 (2.92)
Research Growth Index4.72 (4.65)
Search Engine Demand Index39.34 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (4.26%)6.00%
Case Studies1 (2.13%)4.05%
Observational0 (0.00%)0.25%
Other44 (93.62%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]